Notch protection against apoptosis in T-ALL cells mediated by GIMAP5

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 3, 2010, Pages 201-209

  Chadwick, Nicholas ^a   Zeef, Leo ^a   Portillo, Virginia ^a   Boros, Joanna ^a   Hoyle, Sarah ^a   van Doesburg, Jaap C L ^a   Buckle, Anne Marie ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; GIMAP5; Notch; T ALL

Indexed keywords

CELL PROTEIN; DEXAMETHASONE; GAMMA SECRETASE INHIBITOR; GLUCOCORTICOID; GUANOSINE TRIPHOSPHATASE; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; PROTEIN GIMAP5; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC CODE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; GLUCOCORTICOIDS; GTP-BINDING PROTEINS; HUMANS; JURKAT CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEASE INHIBITORS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77956871809     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.07.006     Document Type: Article

References (39)

1. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66:649-661.
2. Pear W.S., Aster J.C., Scott M.L., Hasserjian R.P., Soffer B., Sklar J., Baltimore D. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 1996, 183:2283-2291.
3. Bellavia D., Campese A.F., Checquolo S., Balestri A., Biondi A., Cazzaniga G., Lendahl U., Fehling H.J., Hayday A.C., Frati L., von Boehmer H., Gulino A., Screpanti I. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc. Natl Acad. Sci. USA 2002, 99:3788-3793.
4. Weng A.P., Ferrando A.A., Lee W., Morris J.P.t., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271.
5. Weng A.P., Nam Y., Wolfe M.S., Pear W.S., Griffin J.D., Blacklow S.C., Aster J.C. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell. Biol. 2003, 23:655-664.
6. Mungamuri S.K., Yang X., Thor A.D., Somasundaram K. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 2006, 66:4715-4724.
7. Sade H., Krishna S., Sarin A. The anti-apoptotic effect of Notch-1 requires p56lck-dependent. Akt/PKB-mediated signaling in T cells. J. Biol. Chem. 2004, 279:2937-2944.
8. Weng A.P., Millholland J.M., Yashiro-Ohtani Y., Arcangeli M.L., Lau A., Wai C., Del Bianco C., Rodriguez C.G., Sai H., Tobias J., Li Y., Wolfe M.S., Shachaf C., Felsher D., Blacklow S.C., Pear W.S., Aster J.C. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006, 20:2096-2109.
9. Palomero T., Lim W.K., Odom D.T., Sulis M.L., Real P.J., Margolin A., Barnes K.C., O'Neil J., Neuberg D., Weng A.P., Aster J.C., Sigaux F., Soulier J., Look A.T., Young R.A., Califano A., Ferrando A.A. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl Acad. Sci. USA 2006, 103:18261-18266.
10. Stahl M., Ge C., Shi S., Pestell R.G., Stanley P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Res. 2006, 66:7562-7570.
11. Choi Y.I., Jeon S.H., Jang J., Han S., Kim J.K., Chung H., Lee H.W., Chung H.Y., Park S.D., Seong R.H. Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression. Proc. Natl Acad. Sci. USA 2001, 98:10267-10272.
12. Ciofani M., Zuniga-Pflucker J.C. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 2005, 6:881-888.
13. Ciofani M., Schmitt T.M., Ciofani A., Michie A.M., Cuburu N., Aublin A., Maryanski J.L., Zuniga-Pflucker J.C. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J. Immunol. 2004, 172:5230-5239.
14. Deftos M.L., He Y.W., Ojala E.W., Bevan M.J. Correlating notch signaling with thymocyte maturation. Immunity 1998, 9:777-786.
15. Chadwick N., Nostro M.C., Baron M., Mottram R., Brady G., Buckle A.M. Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells. Stem Cells 2007, 25:203-210.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
17. Lewis H.D., Leveridge M., Strack P.R., Haldon C.D., O'Neil J., Kim H., Madin A., Hannam J.C., Look A.T., Kohl N., Draetta G., Harrison T., Kerby J.A., Shearman M.S., Beher D. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem. Biol. 2007, 14:209-219.
18. Kaspers G.J., Pieters R., Klumper E., De Waal F.C., Veerman A.J. Glucocorticoid resistance in childhood leukemia. Leuk. Lymphoma 1994, 13:187-201.
19. Kofler R., Schmidt S., Kofler A., Ausserlechner M.J. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J. Endocrinol. 2003, 178:19-27.
20. De Keersmaecker K., Lahortiga I., Mentens N., Folens C., Van Neste L., Bekaert S., Vandenberghe P., Odero M.D., Marynen P., Cools J. In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica 2008.
21. Chadwick N., Zeef L., Portillo V., Fennessy C., Warrander F., Hoyle S., Buckle A.M. Identification of novel Notch target genes in T cell leukaemia. Mol. Cancer 2009, 8:35.
22. Saunders A., Webb L.M., Janas M.L., Hutchings A., Pascall J., Carter C., Pugh N., Morgan G., Turner M., Butcher G.W. Putative GTPase GIMAP1 is critical for the development of mature B and T lymphocytes. Blood 2010, 115:3249-3257.
23. Nitta T., Nasreen M., Seike T., Goji A., Ohigashi I., Miyazaki T., Ohta T., Kanno M., Takahama Y. IAN family critically regulates survival and development of T lymphocytes. PLoS Biol. 2006, 4:e103.
24. MacMurray A.J., Moralejo D.H., Kwitek A.E., Rutledge E.A., Van Yserloo B., Gohlke P., Speros S.J., Snyder B., Schaefer J., Bieg S., Jiang J., Ettinger R.A., Fuller J., Daniels T.L., Pettersson A., Orlebeke K., Birren B., Jacob H.J., Lander E.S., Lernmark A. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 2002, 12:1029-1039.
25. Poussier P., Ning T., Murphy T., Dabrowski D., Ramanathan S. Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats. J. Immunol. 2005, 174:4081-4089.
26. Cousins L., Graham M., Tooze R., Carter C., Miller J.R., Powrie F.M., Macpherson G.G., Butcher G.W. Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene. Gastroenterology 2006, 131:1475-1485.
27. Schulteis R.D., Chu H., Dai X., Chen Y., Edwards B., Haribhai D., Williams C.B., Malarkannan S., Hessner M.J., Glisic-Milosavljevic S., Jana S., Kerschen E.J., Ghosh S., Wang D., Kwitek A.E., Lernmark A., Gorski J., Weiler H. Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood 2008, 112:4905-4914.
28. Barnes M.J., Aksoylar H., Krebs P., Bourdeau T., Arnold C.N., Xia Y., Khovananth K., Engel I., Sovath S., Lampe K., Laws E., Saunders A., Butcher G.W., Kronenberg M., Steinbrecher K., Hildeman D., Grimes H.L., Beutler B., Hobe K. Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice. J. Immunol. 2010, 184:3743-3754.
29. Dalberg U., Markholst H., Hornum L. Both Gimap5 and the diabetogenic BBDP allele of Gimap5 induce apoptosis in T cells. Int. Immunol. 2007, 19:447-453.
30. Kupfer R., Lang J., Williams-Skipp C., Nelson M., Bellgrau D., Scheinman R.I. Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Mol. Immunol. 2007, 44:479-487.
31. Sandal T., Aumo L., Hedin L., Gjertsen B.T., Doskeland S.O. Irod/Ian5: an inhibitor of gamma-radiation- and okadaic acid-induced apoptosis. Mol. Biol. Cell 2003, 14:3292-3304.
32. Pandarpurkar M., Wilson-Fritch L., Corvera S., Markholst H., Hornum L., Greiner D.L., Mordes J.P., Rossini A.A., Bortell R. Ian4 is required for mitochondrial integrity and T cell survival. Proc. Natl Acad. Sci. USA 2003, 100:10382-10387.
33. Keita M., Leblanc C., Andrews D., Ramanathan S. GIMAP5 regulates mitochondrial integrity from a distinct subcellular compartment. Biochem. Biophys. Res. Commun. 2007, 361:481-486.
34. Real P.J., Tosello V., Palomero T., Castillo M., Hernando E., de Stanchina E., Sulis M.L., Barnes K., Sawai C., Homminga I., Meijerink J., Aifantis I., Basso G., Cordon-Cardo C., Ai W., Ferrando A. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat. Med. 2009, 15:50-58.
35. Riml S., Schmidt S., Ausserlechner M.J., Geley S., Kofler R. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ. 2004, 11(Suppl 1):S65-S72.
36. Margolin A.A., Palomero T., Sumazin P., Califano A., Ferrando A.A., Stolovitzky G. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc. Natl Acad. Sci. USA 2009, 106:244-249.
37. Chan S.M., Weng A.P., Tibshirani R., Aster J.C., Utz P.J. Notch signals positively regulate activity of the mTOR pathway in T cell acute lymphoblastic leukemia. Blood 2007.
38. Vilimas T., Mascarenhas J., Palomero T., Mandal M., Buonamici S., Meng F., Thompson B., Spaulding C., Macaroun S., Alegre M.L., Kee B.L., Ferrando A., Miele L., Aifantis I. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 2007, 13:70-77.
39. Liu W.H., Hsiao H.W., Tsou W.I., Lai M.Z. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J. 2007, 26:1660-1669.